Neos con­sid­er­ing of­fers af­ter re­ject­ing PDL’s $300M bid: Reuters

Neos Ther­a­peu­tics $NEOS may be ask­ing for a bid­ding war af­ter re­ject­ing a takeover of­fer from PDL Bio­Phar­ma that came in last week. A …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA